Update At Rocky Mountain -- Fuzhou --
Drug Co., Ltd.
VANCOUVER, British Columbia--(BUSINESS WIRE)--Nov. 2, 2000--The
Board of Directors of Rocky Mountain Ginseng, Inc. (Pink Sheets:RMGG)
are pleased to report that Rocky Mountain (Fuzhou) Drug Co., Ltd. ("RM
Fuzhou") has signed an agreement with the Quanzhou School of
Technology which allows the use of their drug import, wholesale and
retail permit.
This permit is valid for greater Quanzhou with a population of 6
million people and enables RM Fuzhou to immediately import Western
drugs and Western produced healthy food and retail them in Quanzhou.
This permit will also allow RMG to wholesale goods in all of China.
Brian Hodge, President, stated, "After China joins the WTO,
Western companies will not have this opportunity available to them
until 2005." A retail licence has been applied for and approved by
Mr. Lin Bo Qian, Chief Magistrate of Quanzhou.
ABOUT ROCKY MOUNTAIN GINSENG, INC.
Rocky Mountain Ginseng, Inc.'s head office is located in British
Columbia, Canada. The Company exports American ginseng to China as
well as manufactures and processes America ginseng products in China.
Rocky Mountain Ginseng, Inc. holds exclusive world processing and
distribution rights to several innovative value added ginseng products
developed in North America.
Rocky Mountain Ginseng, Inc. purchased Fuzhou Fujian Drug Company
located in China in February 1999. This acquisition included all
necessary drug and hygiene licenses allowing the Company to import,
export, manufacture and distribute ginseng products in all provinces
of China. The Company has completed the construction of its new office
and manufacturing facility in the city of Fuzhou and is currently
producing traditional ginseng products for the Chinese Market. The
Chinese factory employs 42 people in processing, sales, accounting and
management. Rocky Mountain (Fuzhou) Drug Co. Ltd. is the first wholly
owned Canadian Company in the Fujian province.
This press release contains forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities
Litigation Act of 1995. Expression of future goals and similar
expressions reflecting something other than historical fact involve
risks and uncertainties. The actual results the company achieves may
differ materially from any forward-looking statements due to such
risks and uncertainties.
--30--AMP/se*
CONTACT: Rocky Mountain (Fuzhou) Drug Co. Ltd.
Brian A. Hodge, (86) 591-379-7969
rockymt@public.fz.fj.cn
www.RMGGInvestor.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
(c) 1998 Business Wire
Return to Headlines
|
